Table 5 Acute toxicity
From: Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients
| Â | Â | All | No chemoth. | CDDP | Cetuximab |
|---|---|---|---|---|---|
Group | A B C | 36 3 6 | 4 1 5 | 13 2 1 | 19 0 0 |
Completion of RT | Completed Interrupted | 43 2 | 10 0 | 16 0 | 17 2 |
Mucositis | G0 G1 G2 G3 | 6 17 8 12 | 5 3 1 1 | 1 9 4 2 | 0 5 3 9 |
Dermitis | G0 G1 G2 G3 | 6 20 11 6 | 6 3 1 0 | 0 13 3 0 | 0 4 7 6 |
Dysphagia | G0 G1 G2 G3 | 10 11 19 3 | 5 2 2 1 | 3 6 7 0 | 2 3 10 2 |